Trial Profile
Efficacy of ledipasvir/sofosbuvir in treatment-naive non-cirrhotic patients with genotype 1 HCV infection: A real world MADRID-CoRe study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 04 Jan 2017
Price :
$35
*
At a glance
- Drugs Ledipasvir/sofosbuvir (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- 04 Jan 2017 New trial record